IBN’s Bell2Bell Podcast Releases 100th Episode
NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN, a multifaceted financial news and publishing
Globe Newswire31-01-2023, 19:19
Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as First-Line Treatment of Unresectable/Metastatic Melanoma 12-08-2024, 20:30